Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX
Keywords: 1,3,5-Triazine; Benzene sulfonamides; Amino acids; Carbonic anhydrase; Enzyme inhibition; Isoform selectivity;